Dr. Ewa D. Komorowska-Timek, MD

Dr. Komorowska-Timek practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health.

Dr. Komorowska-Timek's NPI, 1710996319, was assigned on August 5, 2006. Dr. Komorowska-Timek graduated from Stanford University School of Medicine in 2000. Dr. Komorowska-Timek holds Michigan license 4301095374.

Dr. Komorowska-Timek's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth, at 100 Michigan St NE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 391-1774.

Dr. Komorowska-Timek's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. The medical group on file is Corewell Health. Dmand AI also links Dr. Komorowska-Timek to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Komorowska-Timek practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Komorowska-Timek's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dmand AI has Dr. Komorowska-Timek's licenses on file in 2 states: Michigan and California.

CMS data shows 16 Medicare services from Dr. Komorowska-Timek across 1 procedure code in 2020, all of them office visits, for 18 Medicare patients. Medicare paid $933 for them. Every service was in an office.

CMS counts 18 Medicare patients who saw Dr. Komorowska-Timek in 2024. 67% of them have high cholesterol, and 61% have high blood pressure. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Komorowska-Timek's median patient age at 51, with 75% women.

In 2024, Dr. Komorowska-Timek wrote 24 Medicare Part D claims. 96% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $26 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Komorowska-Timek for performance year 2024, reported as part of a group. Dr. Komorowska-Timek accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Komorowska-Timek, published from 2015 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Breast Neoplasms and Plastic Surgery Procedures. Dr. Komorowska-Timek has published most often in Plast Reconstr Surg Glob Open. Dr. Komorowska-Timek's most frequent co-authors are Zaahir A. Turfe, Brittany Ann Merrifield, MD and Adam Keith Boettcher, MD.

CMS Open Payments shows 75 general payments to Dr. Komorowska-Timek from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Allergan Inc. paid the most, $624.

Dr. Komorowska-Timek graduated from Stanford University School of Medicine in 2000.